Accepted for/Published in: JMIR Dermatology
Date Submitted: Jun 29, 2023
Date Accepted: Oct 31, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Assessing Mohs Surgery Price Transparency and Variability: The Impact of the Federal Price Transparency Final Rule on Mohs Surgery Pricing at Academic Hospitals
ABSTRACT
With utilization of Mohs Micrographic Surgery (MMS) continuing to expand, understanding the cost transparency and variability of this procedure across hospitals and geographic regions is crucial. New federal legislation called The Price Transparency Final Rule went into effect in 2021, requiring hospitals to disclose the prices for at least 300 services (although not specifically for MMS). Utilizing Turquoise Health, a company that compiles nationwide hospital pricing information, we calculated the percentage of academic hospitals reporting cash and commercial insurance prices for MMS and compared median prices by payment type. For reference, we identified Medicare-reported facility and physician fees for MMS, adjusted by state. The findings indicate that fewer than half of hospitals reported both cash and commercial insurance prices for MMS and that median prices varied substantially across payor types and regions, providing initial characterization of MMS pricing and implying a need for improved pricing transparency.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.